Get started
Author

Geoffrey V. Grandjean

SIK2 Is a Centrosome Kinase Required for Bipolar Mitotic Spindle Formation that Provides a Potential Target for Therapy in Ovarian Cancer
2010 · Ahmed Ashour Ahmed, Zhen Lu, et al. · Cancer Cell · 146
PDF
Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target
2016 · Geoffrey Grandjean, Petrus R. de Jong, et al. · Cancer Research · 78
Modulating Microtubule Stability Enhances the Cytotoxic Response of Cancer Cells to Paclitaxel
2011 · Ahmed Ashour Ahmed, Xiaoyan Wang, et al. · Cancer Research · 54
PDF
A new HIF‐1α/RANTES‐driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice
2016 · Mei Yee Koh, Mihai Gagea, et al. · Hepatology · 46
PDF
An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors
2019 · Martin Indarte, Roisin Puentes, et al. · Cancer Research · 37
Essential Attributes Identified in the Design of a Laboratory Information Management System for a High Throughput siRNA Screening Laboratory
2011 · Geoffrey Grandjean, Ryan Graham, et al. · Combinatorial Chemistry & High Throughput Screening · 3
Correction: An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors
2019 · Martin Indarte, Roisin Puentes, et al. · Cancer Research · 1
Abstract 4448: Identification of a small molecule inhibitor of aldolase A for the targeting of hypoxic cancer cells
2015 · Petrus R. de Jong, Geoffrey V. Grandjean, et al. · Cancer Research
Abstract 2583: Refinement of inhibitors of the KRAS-signaling naocluster protein, CNKSR1, that block oncogenic KRAS signaling and growth
2015 · D. Lynn Kirkpatrick, Martin Indarte, et al. · Cancer Research
Normal Glycolytic Enzyme Activity is Critical for Hypoxia Inducible Factor-1a Activity and Provides Novel Targets for Inhibiting Tumor Growth
2015 · Geoffrey Grandjean · Digital Commons-TMC (Texas Medical Center)
PDF
Abstract 3836: A 3D high throughput RNA1 screen identifies the TLR4 kinase which alters spheroid architecture: a promising therapeutic strategy for pancreatic cancer.
2013 · Geoffrey A. Bartholomeusz, Alex Campos, et al. · Cancer Research
Abstract 2076: Inhibiting glycolysis and HIF1α: a novel approach to cancer therapy.
2013 · Geoffrey V. Grandjean, John Kingston, et al. · Cancer Research
Abstract 5505: A genome-wide siRNA screen for novel regulators of HIF-1α activity in normoxia and hypoxia
2010 · John Kingston, Geoffrey Grandjean, et al. · Cancer Research
Abstract 2188: A high throughput RNAi screen for regulators of thioredoxin in pancreatic cancer cells identifies components of TGFβ-signaling as inducers of thioredoxin expression
2010 · Geoffrey Grandjean, Geoffrey Bartholomeusz, et al. · Cancer Research
Works count: 14
Citation count: 364
H-index: 5
I10-index: 5
Year
Topic
Type